Trial Details
TERMINATEDBasic Information
| Clinical ID | c2407 |
|---|---|
| Identifier | NCT03537157 |
| Trial Title | A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Rifaximin delayed release tablets|OTHER: Placebo |
Participant Information
| Sponsor | Alfasigma S.p.A. |
|---|---|
| City | Rozzano |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2017-11-16 |
|---|---|
| Primary Completion Date | 2020-07-15 |
| Completion Date | 2020-07-29 |